In vivo assessment of the molecular mechanism of inhaled combination ofbeclomethasone and formoterol on cell differentiation factors and airwayremodelling in COPD
- Conditions
- COPDTherapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Investigative Techniques [E05]
- Registration Number
- EUCTR2012-000155-14-AT
- Lead Sponsor
- Med. Universität Wien, Universitätsklinik für Innere Medizin II
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
Planned bronchoscopy
stabel COPD GOLD 0-III (standard therapy)
Age 18-80
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 20
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 20
Exclusion Criteria
exacerbation of COPD, COPD Gold IV
systemic therapy with cortison
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method